VAERS reports by lot

GSK Hepatitis A lot E9G4E: VAERS reports

23 VAERS reports list lot E9G4E as a GSK Hepatitis A vaccine, received between 2019-06-06 and 2022-05-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
4%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological737%
General / Systemic (non-local)316%
Injection-site / Local reaction316%
Allergic / Anaphylactic211%
Musculoskeletal211%
Gastrointestinal15%
Dermatological (non-injection-site)15%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan2
Florida2
Indiana2
Massachusetts1
Oregon1
Minnesota1
Texas1
California1
Colorado1
Virginia1
Illinois1
Arkansas1

Reports by month received

2019-062
2019-071
2019-082
2019-092
2019-101
2019-112
2020-091
2020-111
2021-041
2021-071
2022-015
2022-023
2022-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.